Compounded Semaglutide Ingredients

Last reviewed: June 2, 2026

Last updated: June 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide injection contains the active peptide semaglutide (synthesized identically to branded versions) plus pharmaceutical stabilizers, buffers, and normal saline as the carrier solution. The active ingredient concentration ranges from 2.4 mg/3 mL to 5 mg/mL depending on formulation, with inactive components selected to maintain peptide stability and sterility in licensed 503A pharmacy settings.

Understanding your medication's composition supports informed conversations with your provider about how individual factors—including metabolism, genetics, and GLP-1 receptor sensitivity—may influence your response. PlexusDx emphasizes this personalization lens: knowing what's in your treatment is the first step; knowing how your body processes it is the next.

The Active Ingredient: Semaglutide Peptide

Semaglutide is a 31-amino-acid peptide that functions as a GLP-1 receptor agonist. It stimulates insulin secretion, slows gastric emptying, and promotes satiety signaling in the brain. Whether synthesized for branded Ozempic/Wegovy or compounded formulations, the active molecule structure is identical and must meet USP monograph standards for purity and potency.

Compounded semaglutide peptide is manufactured under pharmaceutical-grade specifications to match the chemistry and bioavailability of branded equivalents. Each injection delivers a precise dose of this active peptide, typically starting at lower micrograms and titrating upward based on clinical response and tolerability. Potency and stability are verified by licensed compounding pharmacies before dispensing.

Inactive Components: Stabilizers, Buffers, and Carriers

Compounded semaglutide formulations include several non-active ingredients chosen to preserve peptide integrity, maintain pH stability, and prevent bacterial contamination. Common components include sodium chloride (saline base), sodium phosphate and potassium phosphate (buffering salts), and in some formulations, benzyl alcohol or phenol as preservatives for multi-dose vials.

Inactive Component	Function in Formulation
Sodium Chloride (0.9%)	Isotonic carrier solution; maintains osmotic balance in tissues
Sodium/Potassium Phosphate	pH buffer; keeps peptide stable across storage temperature range
Benzyl Alcohol or Phenol	Preservative in multi-dose vials; prevents microbial growth
Water for Injection (WFI)	Pharmaceutical-grade diluent meeting USP standards for purity

How Compounded and Branded Formulations Compare

Branded semaglutide (Wegovy, Ozempic) and compounded versions contain the identical active peptide, but licensed compounding pharmacies may use slightly different stabilizer profiles and concentrations. Both must meet FDA and USP standards for sterility, potency, and pyrogenicity. Compounded formulations from 503A pharmacies are not FDA-approved drugs but must comply with pharmacy compounding regulations and quality standards.

The clinical difference, if any, depends on formulation stability and individual absorption patterns. Some patients report similar efficacy across branded and compounded semaglutide; others may notice variation in tolerability or onset of side effects. These differences are often driven by individual factors like metabolic rate, GLP-1 receptor density, and how your body processes the peptide—not the ingredient list itself.

Who Benefits from Understanding Compounded Semaglutide Ingredients

Patients considering compounded semaglutide should understand ingredient transparency and pharmacy sourcing as part of informed consent. Those with specific preservative sensitivities, allergies to stabilizers, or concerns about multi-dose vial storage should discuss formulation options with their provider. Licensed 503A compounding pharmacies can customize ingredient profiles within pharmaceutical guidelines.

Your provider and compounding pharmacist work together to match your medical history, any ingredient sensitivities, and treatment goals to an appropriate compounded semaglutide formulation. If you experience unexpected tolerability issues, ingredient review may reveal actionable information—though most side effects relate to the active peptide itself rather than inactive components.

How PlexusDx Supports a More Personalized Approach

While the ingredient list tells you what's in compounded semaglutide, your genetic predispositions in GLP-1 receptor pathways and metabolic genes may help provide context for why your individual response could differ from others. PlexusDx's Precision Peptide Genetic Test examines variants in related metabolic pathways to reveal predispositions that may influence how your body processes the active peptide and tolerates the medication.

The Precision Peptide Genetic Test does not predict exact medication response or guarantee outcomes; rather, it reveals predispositions in peptide sensitivity and metabolic processing. This genetic context—combined with your clinical history, current medications, and provider assessment—can support a more comprehensive understanding of which compounded formulation and dosing strategy may align with your biology.

Discussing both ingredient composition and genetic predispositions with your provider can inform a more personalized treatment plan. Understanding what's in your compounded semaglutide and how your individual pathways may influence its metabolism creates a foundation for collaborative, informed decisions about dosing, formulation choice, and monitoring throughout your treatment journey.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the active ingredient in compounded semaglutide, according to the post?

The article describes it as semaglutide itself, a 31-amino-acid peptide acting as a GLP-1 receptor agonist that stimulates insulin secretion, slows gastric emptying, and promotes satiety signaling in the brain. It says the molecule's structure is the same whether it is made for a branded product or a compounded one, with the differences sitting in the surrounding formulation.

Which inactive components does the article list?

Its table names sodium chloride at 0.9 percent as the isotonic carrier, sodium and potassium phosphate as pH buffers that hold the peptide stable across a storage temperature range, benzyl alcohol or phenol as preservatives in multi-dose vials, and water for injection as the pharmaceutical-grade diluent. The article says each is chosen to preserve peptide integrity and prevent microbial growth.

Does the post say compounded semaglutide meets the same standards as the branded product?

It says so in one sentence and contradicts itself in the next. The article claims both must meet the same sterility, potency and pyrogenicity standards, then states that compounded formulations from 503A pharmacies are not FDA-approved drugs. The second statement is the accurate one: compounded preparations are not FDA-approved and do not inherit the branded products' approval or trial evidence.

Who does the article say should raise formulation questions with a provider?

It points to people with known preservative sensitivities, allergies to stabilizers, or concerns about multi-dose vials, and says licensed 503A pharmacies can adjust ingredient profiles within pharmaceutical guidelines. The post frames ingredient transparency and pharmacy sourcing as part of informed consent, with the provider and compounding pharmacist matching a formulation to the patient's history.

If someone tolerates it badly, does the post blame the inactive ingredients?

Usually not. The article says an ingredient review may surface useful information when unexpected tolerability problems appear, but that most side effects trace back to the active peptide rather than the buffers, preservatives or carrier solution. It attributes differences people notice between compounded and branded versions more to individual absorption and metabolism than to the ingredient list.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide
• Bioverse Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.